Evans Syndrome Associated With Cytomegalovirus Infection In A 13-Month-Old Girl
Keywords:
Evans syndrome, cytomegalovirus, valganciclovir, infant.Abstract
Introduction: Evans syndrome is a rare autoimmune disorder, characterized by the descent of at least two blood cell lines. Publications of Evans syndrome and cytomegalovirus infection are scarce.
Objective: To examine the case of a girl with Evans syndrome and active cytomegalovirus infection who responded favorably to antiviral therapy.
Case presentation: A 13-month-old girl with a history of prematurity and low birth weight, who attended the consultation for presenting pallor and ecchymosis in the thorax, abdomen and extremities. Laboratory tests found thrombocytopenia and severe anemia after a positive direct Coombs test. She received pulses of methylprednisolone with unfavorable response. The viral load was positive for cytomegalovirus (4019 copies of DNA) and received valganciclovir with favorable evolution at follow-up.
Conclusions: Evans syndrome associated with CMV infection is uncommon. Treatment with valganciclovir may be beneficial for a certain group of patients. However, more studies are needed to demonstrate the efficacy and safety of this treatment in this syndrome; even more so if it is associated with a high viral load.
Downloads
References
Referencias Bibliográficas
1. Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D. Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med. 2018;9:171-84.DOI: 10.2147/JBM.S176144
2. Mannering N, Hansen DL, Frederiksen H. Evans syndrome in children below 13 years of age - A nationwide population-based cohort study. PloS One. 2020;15(4):e0231284.DOI: 10.1371/journal.pone.0231284
3. Mantadakis E, Farmaki E. Natural History, Pathogenesis, and Treatment of Evans Syndrome in Children. J Pediatr Hematol Oncol. 2017;39(6):413-9. DOI: 10.1097/MPH.0000000000000897
4. Luck SE, Wieringa JW, Blázquez-Gamero D, Henneke P, Schuster K, Butler K, et al. Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J. 2017;36(12):1205-13. DOI: 10.1097/INF.0000000000001763
5. Alarcón Allen A, Baquero-Artigao F. Revisión y recomendaciones sobre la prevención, diagnóstico y tratamiento de la infección posnatal por citomegalovirus. An Pediatría. 2011;74(1):52.e1-52.e13. DOI: 10.1016/j.anpedi.2010.05.024
6. Smalisz-Skrzypczyk K, Romiszewski M, Matysiak M, Demkow U, Pawelec K. The Influence of Primary Cytomegalovirus or Epstein-Barr Virus Infection on the Course of Idiopathic Thrombocytopenic Purpura. Adv Exp Med Biol. 2016;878:83-8. DOI: 10.1007/5584_2015_162
7. Rivalta B, Zama D, Pancaldi G, Facchini E, Cantarini ME, Miniaci A, et al. Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease. Front Pediatr. 2019;7:304. DOI: 10.3389/fped.2019.00304
8. DiMaggio D, Anderson A, Bussel JB. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol. 2009;146(1):104-12.DOI: 10.1111/j.1365-2141.2009.07714.x
9. Wu Z, Zhou J, Wei X, Wang X, Li Y, Peng B, et al. The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia. Hematol Amst Neth. 2013;18(5):295-9. DOI: 10.1179/1607845413Y.0000000084
10. Jin MJ, Kim Y, Choi EM, Shim YJ, Kim HS, Suh JK, et al. Clinical characteristics and treatment courses for cytomegalovirus-associated thrombocytopenia in immunocompetent children after neonatal period. Blood Res. 2018;53(2):110-6. DOI: 10.5045/br.2018.53.2.110
11. Papagianni A, Economou M, Tsoutsou E, Athanassiou-Metaxa M. CMV-related immune thrombocytopenic purpura or CMV-induced thrombocytopenia? Br J Haematol. 2010;149(3):454-5.DOI: 10.1111/j.1365-2141.2009.08064.x
12. Nishio Y, Kawano Y, Kawada J-I, Ito Y, Hara S. A case of refractory cytomegalovirus-related thrombocytopenia that achieved complete remission without antiviral therapy. J Infect Chemother Off J Jpn Soc Chemother. 2018;24(12):995-7. DOI: 10.1016/j.jiac.2018.06.004
13. Uemura S, Mori T, Nino N, Sakakibara N, Takafuji S, Myojin S, et al. An infant with refractory cytomegalovirus-induced thrombocytopenia. Clin Case Rep.2020;8(1):75-8.DOI: 10.1002/ccr3.2581
14. Flores-Montes OA, Escobar-Orduño MC, Lozano-Garcidueñas M, Valle-Leal JG. Síndrome de Evans en lactantes. Bol Méd Hosp Infant México. 2017;74(2):141-6.DOI: 10.1016/j.bmhimx.2017.01.004
15. Fujimori K, Yamada M, Maekawa T, Yotani N, Tamura E-I, Imadome K-I, et al. A case of neonatal cytomegalovirus infection with severe thrombocytopenia that was successfully managed with empiric antiviral therapy. IDCases. 2020;19:e00675. DOI: 10.1016/j.idcr.2019.e00675
Downloads
Published
How to Cite
Issue
Section
License
Avisos de derechos de autor propuestos por Creative Commons
1. Política propuesta para revistas que ofrecen acceso abierto
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
